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HIV-associated salivary gland disease (HIV-SGD) is disfig-
uring and causes significant morbidity in the HIV popula-
tion. Evidence detailing the epidemiology of HIV-SGD
suggests the involvement of a viral opportunist in its
pathogenesis, yet the specific etiology of HIV-SGD
remains unclear. To determine the role for an opportunis-
tic virus as the etiologic agent of HIV-SGD, we hypothe-
sized that HIV-SGD was a manifestation of primary
infection or reactivation with a DNA tumor virus, BKV,
during immune suppression. The central hypothesis of
this work is that viral pathogenesis is essential to the
development of salivary gland disease. Results show for
the first time that polyomavirus, BKV, is associated with
HIV-SGD. BKV DNA, RNA, and protein were consistently
detected in salivary gland biopsies and in the peripheral
blood and oral fluids from HIV-SGD patients and not in
control subjects. To confirm the in vivo findings, an in
vitro model was created whereby parotid and submandib-
ular salivary gland cells were productively infected with
BKV, demonstrating each part of the viral life cycle.
Salivary gland tropism was confirmed and the BKV recep-
tor on salivary gland cells was defined. BKV transmission
and pathogenesis is not well understood. Importantly,
these studies suggest a role for BKV in HIV-SGD and that
BKV transmission may occur via the oral route. The long-
term goal of this project is to make critical strides toward
understanding the etiology of SGD in order to go beyond
the ineffective palliative treatment that is currently the
standard of care.
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